Caspases at the crossroads of immune-cell life and death

Nature Reviews Immunology

Volumn 6, Issue 4, 2006, Pages 308-317

  Siegel, Richard M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE INHIBITOR;

APOPTOSIS; CELL ACTIVATION; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL MEMBRANE DEPOLARIZATION; CELL SURVIVAL; DNA CLEAVAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; HEMATOPOIETIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LYMPHOCYTE PROLIFERATION; MITOCHONDRION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DROSOPHILA; HUMANS; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; MODELS, BIOLOGICAL; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

EID: 33645299092     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1809     Document Type: Review

References (85)

1. Boyce, M., Degterev, A. & Yuan, J. Caspases: an ancient cellular sword of Damocles. Cell Death Differ. 11, 29-37 (2004).
2. Creagh, E. M., Conroy, H. & Martin, S. J. Caspase-activation pathways in apoptosis and immunity. Immunol. Rev. 193, 10-21 (2003).
3. Nicholson, D. & Thornberry, N. Caspases: killer proteases. Trends Biochem. Sci. 22, 299-306 (1997).
4. Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561-574 (2004).
5. Leulier, F., Rodriguez, A., Khush, R. S., Abrams, J. M. & Lemaitre, B. The Drosophila caspase Dredd is required to resist gram-negative bacterial infection. EMBO Rep. 1, 353-358 (2000).
6. Hengartner, M. O. The biochemistry of apoptosis. Nature 407, 770-776 (2000).
7. Strasser, A. The role of BH3-only proteins in the immune system. Nature Rev. Immunol. 5, 189-200 (2005).
8. Acehan, D. et al. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell 9, 423-432 (2002).
9. Boatright, K. M. et al. A unified model for apical caspase activation. Mol. Cell 11, 529-541 (2003). This report found that initiator caspases such as caspase-8 could become enzymatically active without undergoing autocatalytic cleavage.
10. Peter, M. E. & Krammer, P. H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10, 26-35 (2003).
11. Siegel, R. M. et al. SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane. J. Cell Biol. 167, 735-744 (2004).
12. Martin, D. A., Siegel, R. M., Zheng, L. & Lenardo, M. J. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHα1) death signal. J. Biol. Chem. 273, 4345-4349 (1998).
13. Tschopp, J., Irmler, M. & Thome, M. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10, 552-558 (1998).
14. Micheau, O. et al. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277, 45162-45171 (2002).
15. Scaffidi, C., Schmitz, I., Krammer, P. H. & Peter, M. E. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274, 1541-1548 (1999).
16. Thome, M. et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521 (1997).
17. Siegel, R. M., Chan, F. K., Chun, H. J. & Lenardo, M. J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nature Immunol. 1, 469-474 (2000).
18. Abbas, A. K. Die and let live: eliminating dangerous lymphocytes. Cell 84, 655-657 (1996).
19. Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol. 1, 489-495 (2000).
20. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317 (1992).
21. Straus, S. E., Sneller, M., Lenardo, M. J., Puck, J. M. & Strober, W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann. Intern. Med. 130, 591-601 (1999).
22. Fleisher, T. A. et al. The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis. Clin. Rev. Allergy Immunol. 20, 109-120 (2001).
23. Fisher, G. H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946 (1995).
24. Hao, Z., Hampel, B., Yagita, H. & Rajewsky, K. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J. Exp. Med. 199, 1355-1365 (2004).
25. Cohen, P. L. & Eisenberg, R. A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-269 (1991).
26. Varfolomeev, E. E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267-276 (1998).
27. Zhang, J., Cado, D., Chen, A., Kabra, N. H. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300 (1998). Using RAG1-deficient-FADD- deficient chimeric mice, this report found a non-apoptotic function for the FADD adaptor protein in lymphocyte development and T-cell proliferation.
28. Yeh, W. C. et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12, 633-642 (2000).
29. Chau, H. et al. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J. Exp. Med. 202, 405-413 (2005).
30. Zhang, Y. et al. Conditional Fas-associated death domain protein (FADD):GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J. Immunol. 175, 3033-3044 (2005). This study showed a role for FADD in peripheral T-cell homeostasis through conditional deletion of a transgene encoding a FADD-GFP fusion protein.
31. Salmena, L. et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17, 883-895 (2003).
32. Zhang, N. & He, Y. W. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J. Exp. Med. 202, 395-404 (2005).
33. Newton, K., Harris, A. W. & Strasser, A. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19, 931-941 (2000).
34. Kang, T. B. et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 173, 2976-2984 (2004).
35. Pellegrini, M. et al. FADD and Caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells. Blood 106, 1581-1589 (2005). References 34 and 35 showed a role for caspase-8 in early haematopoiesis.
36. Palmer, E. Negative selection-clearing out the bad apples from the T-cell repertoire. Nature Rev. Immunol. 3, 383-391 (2003).
37. + thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling. Proc. Natl Acad. Sci. USA 101, 7052-7057 (2004).
38. Doerfler, P., Forbush, K. A. & Perlmutter, R. M. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J. Immunol. 164, 4071-4079 (2000).
39. Alam, A., Cohen, L. Y., Aouad, S. & Sekaly, R. P. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190, 1879-1890 (1999).
40. Kennedy, N. J., Kataoka, T., Tschopp, J. & Budd, R. C. Caspase activation is required for T cell proliferation. J. Exp. Med. 190, 1891-1896 (1999). References 39 and 40 first indicated a role for caspase enzymatic activity in mature T-cell proliferation.
41. Boissonnas, A. et al. Differential requirement of caspases during naive T cell proliferation. Eur. J. Immunol. 32, 3007-3015 (2002).
42. + T cell activation through caspase-8-dependent NF-κB activation. J. Immunol. 174, 5270-5278 (2005).
43. Chun, H. J. et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395-399 (2002). This study described an inherited immunodeficiency syndrome and lymphocyte activation defects linked to a caspase-8 mutation.
44. Wang, J. et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98, 47-58 (1999).
45. Newton, K., Harris, A. W., Bath, M. L., Smith, K. G. C. & Strasser, A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17, 706-718 (1998).
46. Zornig, M., Hueber, A. O. & Evan, C. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice. Curr. Biol. 8, 467-470 (1998).
47. Walsh, C. M. et al. A role for FADD in T cell activation and development. Immunity 8, 439-449 (1998).
48. Beisner, D. R., Chu, I. H., Arechiga, A. F., Hedrick, S. M. & Walsh, C. M. The requirements for fas-associated death domain signaling in mature T cell activation and survival. J. Immunol. 171, 247-256 (2003).
49. O'Reilly, L. A. et al. Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes. Cell Death Differ. 11, 724-736 (2004).
50. Alappat, E. C. et al. Phosphorylation of FADD at serine 194 by CKIα regulates its nonapoptotic activities. Mol. Cell 19, 321-332 (2005).
51. Hua, Z. C., Sohn, S. J., Kang, C., Cado, D. & Winoto, A. A function of fas-associated death domain protein in cell cycle progression localized to a single amino Acid at its C-terminal region. Immunity 18, 513-521 (2003). This study indicated a role for FADD phosphorylation in cell-cycle progression in T cells.
52. + T-cell memory.
53. L modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol. Cell. Biol. 22, 5419-5433 (2002).
54. Salmena, L. & Hakem, R. Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder. J. Exp. Med. 202, 727-732 (2005).
55. Sehra, S. et al. A role for caspases in controlling IL-4 expression in T cells. J. Immunol. 174, 3440-3446 (2005).
56. Silva, E. M. et al. Caspase-8 activity prevents type 2 cytokine responses and is required for protective T cell-mediated immunity against Trypanosoma cruzi infection. J. Immunol. 174, 6314-6321 (2005).
57. Tseveleki, V. et al. Cellular FLIP (long isoform) overexpression in T cells drives Th2 effector responses and promotes immunoregulation in experimental autoimmune encephalomyelitis. J. Immunol. 173, 6619-6626 (2004).
58. Wu, W. et al. Cellular FLIP long form-transgenic mice manifest a Th2 cytokine bias and enhanced allergic airway inflammation. J. Immunol. 172, 4724-4732 (2004).
59. Olson, N. E., Graves, J. D., Shu, G. L., Ryan, E. J. & Clark, E. A. Caspase activity is required for stimulated B lymphocytes to enter the cell cycle. J. Immunol. 170, 6065-6072 (2003).
60. Beisner, D. R., Ch'en, I. L., Kolla, R. V., Hoffmann, A. & Hedrick, S. M. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J. Immunol. 175, 3469-3473 (2005). This report showed a role for caspase-8 in the activation of B cells by TLR ligands, without an apparent effect on activation of NF-κB.
61. Woo, M. et al. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nature Immunol. 4, 1016-1022 (2003). This study indicated an inhibitory role for caspase-3 in cell-cycle progression of B cells.
62. Woo, M. et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12, 806-819 (1998).
63. Sordet, O. et al. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100, 4446-4453 (2002).
64. De Botton, S. et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 100, 1310-1317 (2002).
65. Santambrogio, L. et al. Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells. Nature Immunol. 6, 1020-1028 (2005).
66. Kataoka, T. et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10, 640-648 (2000).
67. Thome, M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nature Rev. Immunol. 4, 348-359 (2004).
68. Lee, K. Y., D'Acquisto, F., Hayden, M. S., Shim, J. H. & Ghosh, S. PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation. Science 308, 114-118 (2005).
69. Che, T. et al. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation. J. Biol. Chem. 279, 15870-15876 (2004).
70. Su, H. et al. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307, 1465-1468 (2005). This study showed defective NF-κB activation in multiple cell types deficient in caspase-8 or harbouring caspase-8 mutations, and indicated a direct association of caspase-8 with the CARMA1-BCL-10-MALT1 complex.
71. Uren, A. G. et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6, 961-967 (2000). This study identified MALT1 as a caspase-related protein with the potential to activate NF-κB.
72. Arechiga, A. F. et al. Cutting edge: FADD is not required for antigen receptor-mediated NF-κB activation. J. Immunol. 175, 7800-7804 (2005).
73. Yu, L. et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500-1502 (2004).
74. Li, M. & Beg, A. A. Induction of necrotic-like cell death by tumor necrosis factor α and caspase inhibitors: novel mechanism for killing virus-infected cells. J. Virol. 74, 7470-7477 (2000).
75. Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485 (1998). References 73-75 showed a role for caspases in protecting cells from non-apoptotic cell death.
76. Choe, K. M., Lee, H. & Anderson, K. V. Drosophila peptidoglycan recognition protein LC (PGRP-LC) acts as a signal-transducing innate immune receptor. Proc. Natl Acad. Sci. USA 102, 1122-1126 (2005).
77. Stoven, S. et al. Caspase-mediated processing of the Drosophila NF-κB factor Relish. Proc. Natl Acad. Sci. USA 100, 5991-5996 (2003).
78. Zhou, R. et al. The role of ubiquitnation in Drosophila innate immunity. J. Biol. Chem. 280, 34048-34055 (2005).
79. Chen, Z. J. Ubiquitin signalling in the NF-κB pathway. Nature Cell Biol. 7, 758-765 (2005).
80. Robertson, G. S., Cracker, S. J., Nicholson, D. W. & Schulz, J. B. Neuroprotection by the inhibition of apoptosis. Brain Pathol. 10, 283-292 (2000).
81. Wencker, D. et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111, 1497-1504 (2003).
82. Stratton, G. A. Some preliminary experiments on vision without inversion of the retinal image. Psychol. Rev. 4, 611-617 (1896).
83. Thornberry, N. A. et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911 (1997). This study reports data that used a peptide-library screen to define the cleavage preferences for caspases.
84. Dohrman, A. et al. Cellular FLIP long form augments caspase activity and death of T cells through heterodimerization with and activation of caspase-8. J. Immunol. 175, 311-318 (2005).
85. Tu, S. et al. In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nature Cell Biol. 8, 72-77 (2006). In this study, biotinylated caspase inhibitor peptides were used to identify the apical caspases in a number of different cell-death pathways.